systemic lupus erythematosus
Conditions
Interventions
The combination of Chinese and western group:Traditional Chinese medicine combined western medicine
Treating by Western Medicine group:Treating by Western medicine (sugar cortical hormone, hydroxychloroquine, and methotrexate, azathioprine, or cyclophosphamide)
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Conform to 4 or more of 11 items of the SLE classification criteria of American rheumatism association in 1997; (2) in accordance with toxic heat,blood stasis and deficiency of the kidney syndrome of traditional Chinese medicine; (3) SLEDAI between 5 to 14 points, and the dosage of glucocorticoid (in terms of prednisone) 1 mg/kg.d; (4) aged between 18 to 60 years old; (5) volunteered for the experiment and agree to sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) NPSLE patients or patients with lupus crisis; (2) With complications such as organs severe disease, mental disease, tumor and other diseases; (3) Cannot tolerate this study's medication; (4) Pregnant and nursing women; (5) participating in other clinical trials; (6) Other reasons are not suitable for clinical subjects, according to the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SLE disease index; | — |
Secondary
| Measure | Time frame |
|---|---|
| LupusQoL;frequency of Infection;resurgence of diseases;The dosage of glucocorticoid;the time of mild or severe And severe disease outbreaks of disease;Security Index; | — |
Countries
China
Contacts
Public ContactChengping Wen
Outcome results
None listed